Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov 8;15(11):e48499.
doi: 10.7759/cureus.48499. eCollection 2023 Nov.

Neurosarcoidosis: A Unique Presentation of a Rare Disease

Affiliations
Case Reports

Neurosarcoidosis: A Unique Presentation of a Rare Disease

Kyrillos Girgis et al. Cureus. .

Abstract

Sarcoidosis is defined as an immune-mediated multi-organ granulomatous disease with unknown etiology, which is characterized by the presence of multiple non-caseating granulomas in the absence of a definite infective or toxic cause. Neurosarcoidosis (NS) occurs when sarcoid granulomas invade the central or peripheral nervous systems. Sarcoidosis usually presents with non-specific manifestations, including dry cough, fatigue, night sweats, weight loss, skin changes, and eye manifestations. Many patients who develop NS present with neurological manifestations within two years of being diagnosed with sarcoidosis. Herein, we present a case of newly diagnosed sarcoidosis in a 49-year-old male patient initially presenting with neurological manifestations of unknown origin, later identified as NS on peripheral lymph node biopsy with non-caseating granuloma.

Keywords: neurological deficits; neurosarcoidosis; rare disease; rare presentation; sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. MRI of the lumbar spine showing nodular contiguous ventral and dorsal leptomeningeal enhancement (blue arrows)
Figure 2
Figure 2. MRI of the brain showing abnormal fluid-attenuated inversion recovery (FLAIR) signals in the periventricular regions (black arrows)
Figure 3
Figure 3. CT of the chest showing bilateral axillary lymphadenopathy (blue arrows)
Figure 4
Figure 4. CT of the chest showing two lung nodules in the right middle lobe (black arrows)
Figure 5
Figure 5. MRI of the brain with contrast showing abnormal enhancement of the posterior portions of the bilateral optic nerves (blue arrows) and optic chiasm (black arrows)

References

    1. Neurosarcoidosis: a clinical approach to diagnosis and management. Ibitoye RT, Wilkins A, Scolding NJ. J Neurol. 2017;264:1023–1028. - PMC - PubMed
    1. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurol Neuroimmunol Neuroinflamm. 2021;8 - PMC - PubMed
    1. Sarcoidosis: causes, diagnosis, clinical features, and treatments. Jain R, Yadav D, Puranik N, Guleria R, Jin JO. J Clin Med. 2020;9:1081. - PMC - PubMed
    1. Neurosarcoidosis: clinical manifestations, investigation and treatment. Kidd DP. Pract Neurol. 2020;20:199–212. - PubMed
    1. Neurosarcoidosis presenting as longitudinally extensive myelitis: diagnostic assessment, differential diagnosis, and therapeutic approach. Cicia A, Nociti V, Bianco A, De Fino C, Carlomagno V, Mirabella M, Lucchini M. Transl Neurosci. 2022;13:191–197. - PMC - PubMed

Publication types

LinkOut - more resources